In the Boardroom
Refine Search
Biotechnology
North Carolina, USA-based KBI Biopharma has appointed Jean-Baptiste Agnus as chief business officer, joining the company’s executive team. 17 April 2024
Biotechnology
US clinical-stage cell therapy developer Vittoria Biotherapeutics has announced that Keith Westby has joined the company as its inaugural chief operating officer (COO). 16 April 2024
Pharmaceutical
Italian family-owned drugmaker Chiesi Farmaceutici has appointed Richard Smith as vice president and business unit leader of the US AIR at Chiesi USA. 16 April 2024
Biotechnology
Swiss ophthalmology firm Oculis Holding today announced the appointment of Dr Snehal Shah, executive leader with over two decades of research and development (R&D) and regulatory experience, to the role of president of R&D. 10 April 2024
Biotechnology
Swiss drugmaker Novartis has revealed fresh plans to slim down its workforce, with a further 680 US and Swiss positions
to be cut. 10 April 2024
Biotechnology
Asklepios BioPharmaceutical, the wholly-owned but independently operated subsidiary of Bayer, has appointed a new chief scientific officer. 9 April 2024
Biotechnology
Seaport Therapeutics has become the latest founded entity to be created by PureTech Health, the Boston-based biotech behind Karuna Therapeutics, which was recently acquired by Bristol Myers Squibb for $14 billion. 9 April 2024
Pharmaceutical
Family-controlled Spanish pharma company Esteve today announced the appointment of Jacob Tolstrup as chief business development officer, part of the executive management and reporting to Staffan Schüberg, chief executive of the company. 8 April 2024
Pharmaceutical
San Diego, USA-based drugmaker Acadia Pharmaceuticals has appointed Dr Elizabeth Thompson as executive vice president, head of R&D. 6 April 2024
Biotechnology
In a filing with the US Securities and Exchange Commission (SEC), Canadian biotech Zymeworks has revealed the sudden replacement of its chief financial officer. 4 April 2024
Biotechnology
Former Forbion partner Juliette Audet has been appointed chief business officer (CBO) at Netherlands-based NewAmsterdam Pharma Company. 3 April 2024
Pharmaceutical
Swiss contract development and manufacturing organization (CDMO) Lonza today announced that Wolfgang Wienand has been appointed chief executive (CEO). 2 April 2024
Biotechnology
US clinical-stage biotech Zura Bio on Thursday announced the appointment of Robert Lisicki as chief executive (CEO), effective April 8, 2024. 29 March 2024
Biotechnology
Poseida Therapeutics has appointed Syed Rizvi as chief medical officer. 26 March 2024
Pharmaceutical
Germany's Bayer has announced a restructure of the executive leadership team of its Pharmaceuticals Division. 22 March 2024
Pharmaceutical
This year could be a crucial one for Maat Pharma, a French microbiome company with a focus on cancer. 22 March 2024
Biotechnology
Guy Braunstein, who has served as Idorsia’s chief medical officer (CMO) since 2022, will retire at the end of this month. 22 March 2024
Biotechnology
Germany’s BioNTech has announced the appointment of Annemarie Hanekamp as the company’s new chief commercial officer, succeeding Sean Marett. 20 March 2024
Pharmaceutical
San Diego, USA-headquartered Conduit Pharmaceuticals, a disease agnostic life science company, today announced the appointment of Dr Joanne Holland as chief scientific officer (CSO). 19 March 2024
Pharmaceutical
US radiopharmaceuticals-focussed company Lantheus Holdings has announced the promotion of Amanda Morgan to chief commercial officer (CCO) and her elevation to be a member of the company’s executive team, effective March 25, 2024. 19 March 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Biotechnology
US clinical-stage biotech Spyre Therapeutics says it has appointed of Sheldon Sloan as its chief medical officer (CMO). 3 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the appointments of Andre Hoekema as chairman of the board and Cora Griffin as head of business development. 2 October 2024
Biotechnology
NK:IO, a London startup developing a cell therapy for treating solid tumors, has announced the appointment of a permant chief executive and the finalization of a seed funding round. 2 October 2024
Biotechnology
Halda Therapeutics, a US biotech company advancing cancer treatments, announced the appointment of Christian Schade as president and chief executive. 1 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Biotechnology
AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has announced the appointment of Jane Rhodes as chief executive officer. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Biotechnology
USA-based engineered regulatory T cells (Tregs) company GentiBio today announced the appointment of Dr Mark Bach as chief medical officer. 30 September 2024
Pharmaceutical
Acadia Pharmaceuticals has appointed Catherine Owen Adams to succeed Steve Davis as chief executive (CEO) and a member of its board of directors. 28 September 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze